DataMEDS AI, Inc. (MEDS)
DataMEDS AI, Inc. operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Tampa, FL, US. The stock last traded at $1.31, down 5.56% on the session, giving a market capitalisation of $3.4M. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -545.7%. Its beta of -1.52 implies it has historically moved less than the broad market.
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
DataMEDS AI, Inc. is most often compared with the following Healthcare names: